Skip to content
Top Stories

Survey shows low awareness of Hong Kong breast cancer screening pilot scheme

News Hong Kong Editorial team · · Reading time 6min read · Views 0 ·
Key — A survey by the Global Chinese Breast Cancer Organization found that 86.6% of breast cancer patients were unaware of the details of the government's breast cancer screening pilot scheme.

A survey conducted by the Global Chinese Breast Cancer Organization found that 86.6% of breast cancer patients were unaware of the specific details of the government's Breast Cancer Screening Pilot Scheme. The study, which collected 308 valid questionnaires between May and August 2026, revealed that only 5.5% of respondents had participated in the current government pilot scheme.

Current screening limitations

The existing government pilot scheme is restricted to women with a family history of breast cancer and currently covers 2D mammography. This limitation contrasts with clinical data regarding patient demographics. Surgeon Chow Tsz-yan stated that approximately 80% of breast cancer patients do not have a family history of the disease. Surgeon Chow Tsz-yan noted that ideally, screening should identify asymptomatic patients, but the current scheme only covers those with a family history.

The Department of Health reported that all breast cancer cases diagnosed under the pilot scheme as of the end of June 2026 were at Stage 1 or below. While the Department of Health provides a free online breast cancer risk assessment tool for Hong Kong Chinese women aged 44 to 69 without a history of breast cancer, the pilot scheme remains focused on high-risk individuals, specifically those with certain genetic mutations or a strong family history of breast or ovarian cancer.

Demand for advanced technology

The survey highlighted a significant preference for advanced imaging technology among patients. According to the findings, 90.8% of respondents are willing to pay the price difference to choose 3D mammography over 2D mammography. Regarding the specific amount patients are willing to pay, Oriental Daily News reported that 51.6% of respondents are willing to pay a price difference of HK$500 or less, while 32% are willing to pay a price difference of HK$500 to HK$1,000.

In response to these preferences, 96.4% of respondents agree with the government increasing subsidies for 3D mammography. Wong Tin-fung, the Chairperson of the Global Chinese Breast Cancer Organization, stated that the government should expand the scope of the screening program to include medium and general risk individuals and lower the screening age to 40.

Proposed age and risk adjustments

Beyond technology, the survey indicated support for structural changes to the screening timeline. Oriental Daily News reported that 85.4% of respondents support lowering the screening age for medium and general risk groups from 44 to 40 years old.

The necessity for expanded screening is underscored by health statistics. The Hong Kong Cancer Data Service estimates that 1 in 13 Hong Kong women will have breast cancer before age 75. Breast cancer remains the third leading cause of death among women in Hong Kong, following lung and colorectal cancer.

This article was written with AI assistance from multiple news reports and is reviewed by our editors under our editorial principles. Editorial Standards · Tips & Contact

How did you like this post?

Comments 0

Be the first to comment

Contact us

← News Hong Kong Home
News Hong Kong Get new posts by emailSubscribe to receive new content via email. Unsubscribe anytime.
Was this helpful?Share it with friends & social